Shandong Sinobioway Biomedicine Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 434.430 million compared to CNY 492.895 million a year ago. Operating income was CNY 60.776 million compared to CNY 27.720 million a year ago. Net income was CNY 49.319 million compared to CNY 12.592 million a year ago. Basic earnings per share from continuing operations was CNY 0.0748 compared to CNY 0.0191 a year ago.